Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
59.95
+0.70 (1.18%)
Apr 25, 2025, 11:52 AM EDT - Market open

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $7.41 billion as of April 25, 2025. Its market cap has increased by 45.51% in one year.

Market Cap
7.41B
Enterprise Value
8.26B
1-Year Change
45.51%
Ranking
Category
Stock Price
$59.95

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $7.41B, an increase of 91,329.90%. That is a compound annual growth rate of 38.10%.

History

DateMarket Cap% Change
Apr 24, 20257.30B19.96%
Dec 31, 20246.08B24.59%
Dec 29, 20234.88B-36.54%
Dec 30, 20227.69B35.91%
Dec 31, 20215.66B-1.95%
Dec 31, 20205.77B122.23%
Dec 31, 20192.60B22.85%
Dec 31, 20182.11B-26.67%
Dec 29, 20172.88B125.43%
Dec 30, 20161.28B-42.33%
Dec 31, 20152.22B83.35%
Dec 31, 20141.21B-29.21%
Dec 31, 20131.71B126.01%
Dec 31, 2012756.30M-23.30%
Dec 30, 2011986.10M23.98%
Dec 31, 2010795.40M47.84%
Dec 31, 2009538.00M17.96%
Dec 31, 2008456.10M-17.36%
Dec 31, 2007551.90M6.38%
Dec 29, 2006518.80M469.48%
Dec 30, 200591.10M-13.07%
Dec 31, 2004104.80M1,193.83%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 772.03B
UnitedHealth Group 386.16B
Johnson & Johnson 372.77B
AbbVie 319.07B
Novo Nordisk 276.96B
Abbott Laboratories 224.39B
AstraZeneca 215.41B
Novartis AG 210.89B
Market Cap Rankings